# Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/determining-donor-eligibility-for-autologous-donors-of-blood-and-blood-components-intended-solely-for-autologous-use-compliance-policy-guidance-for-industry/66ca6a85-aebe-4b20-a0ba-d0f7e4e393d3

> FDA guidance document: Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy:  Guidance for Industry. Issue date: August 01, 2016. Get complete insights and analysis.

---

## Details

- Title: Determining Donor Eligibility for Autologous Donors of Blood and Blood Components Intended Solely for Autologous Use - Compliance Policy:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2016-08-01
- Last Changed: 2019-03-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-2071">FDA-2016-D-2071</a>

## Related Documents

- [Validation of Procedures for Processing of Human Tissues Intended for Transplantation:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/validation-of-procedures-for-processing-of-human-tissues-intended-for-transplantation-guidance-for-industry/098dfce7-8124-4658-98c8-d92a922f6766)
- [Revised Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products Who Have Received Human-Derived Clotting Factor Concentrates:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/revised-recommendations-for-determining-eligibility-of-donors-of-human-cells-tissues-and-cellular-and-tissue-based-products-who-have-received-human-derived-clotting-factor-concentrates-guidance-for-industry/46133f75-38b3-4404-897e-4a18275401f5)
- [Biological Product Deviation Reporting for Blood and Plasma Establishments:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/biological-product-deviation-reporting-for-blood-and-plasma-establishments-guidance-for-industry/6c58653c-8367-4da8-9b28-4e92356ee9c7)